DONATO, FRANCESCA
DONATO, FRANCESCA
SCIENZE MEDICHE
A contribution to the validation of the Italian version of the work-related quality of life scale
2020-01-01 Garzaro, Giacomo; Clari, Marco; Donato, Francesca; Dimonte, Valerio; Mucci, Nicola; Easton, Simon; Van Laar, Darren; Gatti, Paola; Pira, Enrico
Comparative in Vitro Cytotoxicity of Realistic Doses of Benchmark Multi-Walled Carbon Nanotubes towards Macrophages and Airway Epithelial Cells
2019-01-01 Di Cristo, L.; Bianchi, M.G.; Chiu, M.; Taurino, G.; Donato, F.; Garzaro, G.; Bussolati, O.; Bergamaschi, E.
Continuous Therapy Versus Fixed Duration of Therapy in Patients With Newly Diagnosed Multiple Myeloma
2015-01-01 Palumbo, Antonio; Gay, Francesca; Cavallo, Federica; Di Raimondo, Francesco; Larocca, Alessandra; Hardan, Izhar; Nagler, Arnon; Petrucci, Maria T; Hajek, Roman; Pezzatti, Sara; Delforge, Michel; Patriarca, Francesca; Donato, Francesca; Cerrato, Chiara; Nozzoli, Chiara; Yu, Zhinuan; Boccadifuoco, Luana; Caravita, Tommaso; Benevolo, Giulia; Guglielmelli, Tommasina; Vincelli, Donatella; Jacques, Christian; Dimopoulos, Meletios A; Ciccone, Giovannino; Musto, Pellegrino; Corradini, Paolo; Cavo, Michele; Boccadoro, Mario
Current Phase II investigational proteasome inhibitors for the treatment of multiple myeloma
2014-01-01 Bringhen S.; Gay F.; Donato F.; Troia R.; Mina R.; Palumbo A.
Evolution of the concept OS&H from the second Post-war to today: From prescriptive system to assessment and management of risks in system quality -The extended model in collaboration with large Facilities. Evolution of multidisciplinary culture of safety and OS&H
2018-01-01 Pira E., Garzaro G., De Cillis E., Donato F., Ciocan C., Patrucco M.
Exposure to asbestos: past, present and future
2018-01-01 Enrico, Pira; Francesca, Donato; Luisa, Maida; Gianluigi, Discalzi
Exposure to glyphosate and risk of non-Hodgkin lymphoma and multiple myeloma: an updated meta-analysis
2020-01-01 Donato, Francesca; Pira, Enrico; Ciocan, Catalina; Boffetta, Paolo
Hazard determinants of carbon nanotubes (cnts) driving molecular initiating events (mies) in adverse outcome pathways (aops) of airways diseases
2018-01-01 E Bergamaschi, E Aldieri, E Gazzano, E Polimeni, C Riganti, O Bussolati, M Allegri, MG Bianchi, F Donato, A Marucco, I Fenoglio
Monoclonal antibodies currently in Phase II and III trials for multiple myeloma
2014-01-01 Donato F.; Gay F.; Bringhen S.; Troia R.; Palumbo A.
Mortality and cancer morbidity among cement production workers: a meta-analysis
2016-01-01 Donato, Francesca; Garzaro, Giacomo; Pira, Enrico; Boffetta, Paolo*
Mortality from cancer and other causes among Italian chrysotile asbestos miners
2017-01-01 Pira, Enrico; Romano, Canzio; Donato, Francesca; Pelucchi, Claudio; Vecchia, Carlo La; Boffetta, Paolo*
Nanotubi e nanofibre di carbonio: esposizione occupazionale e possibili effetti sulla salute
2018-01-01 Bergamaschi E, Donato F, Pira E, Garzaro G, Rossi F, Fenoglio I
Occupational and environmental exposure to polychlorinated biphenyls and risk of non-Hodgkin lymphoma: A systematic review and meta-analysis of epidemiology studies
2019-01-01 Catalani S.; Donato F.; Tomasi C.; Pira E.; Apostoli P.; Boffetta P.
Occupational exposure to formaldehyde and risk of non hodgkin lymphoma: A meta-Analysis
2019-01-01 Catalani S.; Donato F.; Madeo E.; Apostoli P.; De Palma G.; Pira E.; Mundt K.A.; Boffetta P.
Plasma levels of polychlorinated biphenyls (PCB) and the risk of soft tissue sarcoma
2019-01-01 Guercio V.; Donato F.; Pelucchi C.; Verga F.; Passini V.; Galeone C.; Negri E.; Garzaro G.; Boffetta P.; La Vecchia C.; Tavani A.; Pira E.
Risk of mesothelioma after cessation of asbestos exposure: a systematic review and meta-regression
2019-01-01 Boffetta P.; Donato F.; Pira E.; Luu H.N.; La Vecchia C.
Upper limb work-related musculoskeletal disorders in operating room nurses: A multicenter cross-sectional study
2019-01-01 Clari M.; Garzaro G.; Di Maso M.; Donato F.; Godono A.; Paleologo M.; Dimonte V.; Pira E.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A contribution to the validation of the Italian version of the work-related quality of life scale | 2020 | Garzaro, Giacomo; Clari, Marco; Donato, Francesca; Dimonte, Valerio; Mucci, Nicola; Easton, Simon; Van Laar, Darren; Gatti, Paola; Pira, Enrico | |
| Comparative in Vitro Cytotoxicity of Realistic Doses of Benchmark Multi-Walled Carbon Nanotubes towards Macrophages and Airway Epithelial Cells | 2019 | Di Cristo, L.; Bianchi, M.G.; Chiu, M.; Taurino, G.; Donato, F.; Garzaro, G.; Bussolati, O.; Bergamaschi, E. | |
| Continuous Therapy Versus Fixed Duration of Therapy in Patients With Newly Diagnosed Multiple Myeloma | 2015 | Palumbo, Antonio; Gay, Francesca; Cavallo, Federica; Di Raimondo, Francesco; Larocca, Alessandra; Hardan, Izhar; Nagler, Arnon; Petrucci, Maria T; Hajek, Roman; Pezzatti, Sara; Delforge, Michel; Patriarca, Francesca; Donato, Francesca; Cerrato, Chiara; Nozzoli, Chiara; Yu, Zhinuan; Boccadifuoco, Luana; Caravita, Tommaso; Benevolo, Giulia; Guglielmelli, Tommasina; Vincelli, Donatella; Jacques, Christian; Dimopoulos, Meletios A; Ciccone, Giovannino; Musto, Pellegrino; Corradini, Paolo; Cavo, Michele; Boccadoro, Mario | |
| Current Phase II investigational proteasome inhibitors for the treatment of multiple myeloma | 2014 | Bringhen S.; Gay F.; Donato F.; Troia R.; Mina R.; Palumbo A. | |
| Evolution of the concept OS&H from the second Post-war to today: From prescriptive system to assessment and management of risks in system quality -The extended model in collaboration with large Facilities. Evolution of multidisciplinary culture of safety and OS&H | 2018 | Pira E., Garzaro G., De Cillis E., Donato F., Ciocan C., Patrucco M. | |
| Exposure to asbestos: past, present and future | 2018 | Enrico, Pira; Francesca, Donato; Luisa, Maida; Gianluigi, Discalzi | |
| Exposure to glyphosate and risk of non-Hodgkin lymphoma and multiple myeloma: an updated meta-analysis | 2020 | Donato, Francesca; Pira, Enrico; Ciocan, Catalina; Boffetta, Paolo | |
| Hazard determinants of carbon nanotubes (cnts) driving molecular initiating events (mies) in adverse outcome pathways (aops) of airways diseases | 2018 | E Bergamaschi, E Aldieri, E Gazzano, E Polimeni, C Riganti, O Bussolati, M Allegri, MG Bianchi, F Donato, A Marucco, I Fenoglio | |
| Monoclonal antibodies currently in Phase II and III trials for multiple myeloma | 2014 | Donato F.; Gay F.; Bringhen S.; Troia R.; Palumbo A. | |
| Mortality and cancer morbidity among cement production workers: a meta-analysis | 2016 | Donato, Francesca; Garzaro, Giacomo; Pira, Enrico; Boffetta, Paolo* | |
| Mortality from cancer and other causes among Italian chrysotile asbestos miners | 2017 | Pira, Enrico; Romano, Canzio; Donato, Francesca; Pelucchi, Claudio; Vecchia, Carlo La; Boffetta, Paolo* | |
| Nanotubi e nanofibre di carbonio: esposizione occupazionale e possibili effetti sulla salute | 2018 | Bergamaschi E, Donato F, Pira E, Garzaro G, Rossi F, Fenoglio I | |
| Occupational and environmental exposure to polychlorinated biphenyls and risk of non-Hodgkin lymphoma: A systematic review and meta-analysis of epidemiology studies | 2019 | Catalani S.; Donato F.; Tomasi C.; Pira E.; Apostoli P.; Boffetta P. | |
| Occupational exposure to formaldehyde and risk of non hodgkin lymphoma: A meta-Analysis | 2019 | Catalani S.; Donato F.; Madeo E.; Apostoli P.; De Palma G.; Pira E.; Mundt K.A.; Boffetta P. | |
| Plasma levels of polychlorinated biphenyls (PCB) and the risk of soft tissue sarcoma | 2019 | Guercio V.; Donato F.; Pelucchi C.; Verga F.; Passini V.; Galeone C.; Negri E.; Garzaro G.; Boffetta P.; La Vecchia C.; Tavani A.; Pira E. | |
| Risk of mesothelioma after cessation of asbestos exposure: a systematic review and meta-regression | 2019 | Boffetta P.; Donato F.; Pira E.; Luu H.N.; La Vecchia C. | |
| Upper limb work-related musculoskeletal disorders in operating room nurses: A multicenter cross-sectional study | 2019 | Clari M.; Garzaro G.; Di Maso M.; Donato F.; Godono A.; Paleologo M.; Dimonte V.; Pira E. |